Organon Overview

  • Year Founded
  • 1923

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

  • Investments
  • 1

Organon General Information

Description

Provider of drugs for the treatment of schizophrenia in adults. The company provides drugs for the treatment of schizophrenia in adults, and for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults, as monotherapy or as adjunctive therapy with either lithium or valproate.

Contact Information

Website
www.saphris.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Oss
  • Netherlands
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Drug Discovery
Other Healthcare Services
Parent Company
Corporate Office
  • Oss
  • Netherlands

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Organon Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Organon‘s full profile, request access.

Request a free trial

Organon Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Organon‘s full profile, request access.

Request a free trial

Organon Investments (1)

Organon’s most recent deal was a Accelerator/Incubator with NAWAT Health for . The deal was made on 17-Oct-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
NAWAT Health 17-Oct-2024 Accelerator/Incubator Information Services (B2C)
To view Organon’s complete investments history, request access »

Organon FAQs

  • When was Organon founded?

    Organon was founded in 1923.

  • Where is Organon headquartered?

    Organon is headquartered in Oss, Netherlands.

  • What industry is Organon in?

    Organon’s primary industry is Pharmaceuticals.

  • Is Organon a private or public company?

    Organon is a Private company.

  • What is Organon’s current revenue?

    The current revenue for Organon is .

  • Who are Organon’s investors?

    Merck & Co. has invested in Organon.

  • When was Organon acquired?

    Organon was acquired on 02-Dec-2013.

  • Who acquired Organon?

    Organon was acquired by Forest Laboratories.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »